EMA launches public registry of small and medium-sized drug companies
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has launched a public registry of small and medium-sized drug companies registered as SMEs with the agency. The aim of the initiative is to facilitate greater interaction amongst the SMEs.